These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15767337)

  • 1. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
    Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of serrated aberrant crypt foci among smokers.
    Anderson JC; Pleau DC; Rajan TV; Protiva P; Swede H; Brenner B; Heinen CD; Lambrecht RW; Rosenberg DW
    Am J Gastroenterol; 2010 Jul; 105(7):1648-54. PubMed ID: 20234347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant crypt foci: what we know and what we need to know.
    Gupta AK; Pretlow TP; Schoen RE
    Clin Gastroenterol Hepatol; 2007 May; 5(5):526-33. PubMed ID: 17433788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
    Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
    N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.
    Martin C; Connelly A; Keku TO; Mountcastle SB; Galanko J; Woosley JT; Schliebe B; Lund PK; Sandler RS
    Gastroenterology; 2002 Dec; 123(6):1770-7. PubMed ID: 12454832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
    Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
    Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
    Stevens RG; Swede H; Heinen CD; Jablonski M; Grupka M; Ross B; Parente M; Tirnauer JS; Giardina C; Rajan TV; Rosenberg DW; Levine J
    Cancer Lett; 2007 Apr; 248(2):262-8. PubMed ID: 16950561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
    Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative.
    Paskett ED; Reeves KW; Rohan TE; Allison MA; Williams CD; Messina CR; Whitlock E; Sato A; Hunt JR
    J Natl Cancer Inst; 2007 Nov; 99(22):1729-35. PubMed ID: 18000222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonsteroidal anti-inflammatory drugs and the risk of polyposis, colon carcinoma and rectal carcinoma].
    Gao X; Sun S; Sun F; Li M; Sun H; Zhang W; Song S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):332-5. PubMed ID: 12411196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.